|Bid||182.70 x 1000|
|Ask||183.40 x 900|
|Day's Range||182.88 - 187.15|
|52 Week Range||176.36 - 242.99|
|Beta (5Y Monthly)||0.66|
|PE Ratio (TTM)||24.20|
|Earnings Date||Oct 27, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||258.45|
Subscribe to Yahoo Finance Plus to view Fair Value for VRTXLearn more
BOSTON, October 22, 2021--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third-quarter 2021 financial results on Tuesday, November 2, 2021 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International).
Any biotech acquisition is a good one -- at the right price, of course.
The best investing alternatives have a solid business model combined with tremendous growth prospects. You'll need nearly half of your initial $500 -- around $220 -- to buy one share of Nvidia (NASDAQ: NVDA). The obvious opportunity for Nvidia is in gaming.